Sudeep Pharma Limited (NSE:SUDEEPPHRM)

India · Delayed Price · Currency is INR

880.00

+23.75 (2.77%)

Jul 31, 2026, 3:29 PM IST

20.55% (1Y)

Market Cap	99.51B
Revenue (ttm)	6.42B +39.8%
Net Income	1.73B +29.8%
EPS	15.50 +26.2%
Shares Out	112.95M
PE Ratio	56.84
Forward PE	51.52
Dividend	1.50 (0.17%)
Ex-Dividend Date	Jul 23, 2026

Volume	282,842
Open	861.90
Previous Close	856.25
Day's Range	856.65 - 909.00
52-Week Range	524.05 - 908.00
Beta	n/a
Analysts	Sell
Price Target	730.00 (-17.05%)
Earnings Date	Aug 4, 2026

About Sudeep Pharma

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-drie... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1989

Employees 525

Stock Exchange National Stock Exchange of India

Ticker Symbol SUDEEPPHRM

Full Company Profile

Financial Performance

In fiscal year 2026, Sudeep Pharma's revenue was 6.42 billion, an increase of 27.94% compared to the previous year's 5.02 billion. Earnings were 1.73 billion, an increase of 24.63%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for SUDEEPPHRM stock is "Sell." The 12-month stock price target is ₹730.00, which is a decrease of -17.05% from the latest price.

Price Target

₹730.00

(-17.05% downside)

Analyst Consensus: Sell

Stock Forecasts